None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - Carcinoma located in the colon and rectosigmoid defined as a tumour located 15 cm above the anal verge by coloscopy or above the sacral promontory as seen preoperatively - Stage 1, 2 and 3 carcinoma - Surgical treatment with curative intent - Qualified for routine follow-up attendance by surgeon according to the national guideline. - Patients with temporary stoma and who received adjuvant chemotherapy are also eligible.
Exclusion criteria
Exclusion criteria: - Stage IV colorectal tumours - Hereditary colorectal cancer - Colorectal cancer in patients with inflammatory bowel disease - Rectal cancer - (Sub)total colectomy or proctocolectomy - History of second primary cancer (except basal cell carcinoma of the skin) within the last 15 years - Participation in other (clinical) research, which will affect the outcome measurements of this trial - Permanent open wounds after surgery or other conditions where specialised care is needed - Any other condition that warrants increased intensity of surveillance with respect to colon cancer follow-up - Not able to speak Dutch or English
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality of life and patients' satisfaction | — |
Secondary
| Measure | Time frame |
|---|---|
| Physical outcomes, psychosocial outcomes, number of investigations, referrals and related communication between secondary and primary care, (time) of recurrence detection, protocol adherence, attention to preventive care, cost effectiveness, and preference of care at the end of the trial | — |
Contacts
Academic Medical Center (AMC), P.O. Box 22660